Dr. Paul Charles Anderson, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 2270 Nistler Rd, Delta Junction, AK 99737 Phone: 907-895-4274 Fax: 907-895-4276 |
Timothy Allen Mathews, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 2270 Nistler Rd, Delta Junction, AK 99737 Phone: 907-895-4274 Fax: 907-895-4276 |
Dr. Jeremy G. Bauer, DDS Dentist Medicare: Medicare Enrolled Practice Location: 2270 Nistler Rd, Delta Junction, AK 99737 Phone: 907-895-4274 Fax: 907-895-4276 |
News Archive
Available research suggests that noninvasive stimulation of a specific brain area can reduce food cravings—particularly for high-calorie, "appetitive" foods, according to a review in the Psychosomatic Medicine: Journal of Biobehavioral Medicine, the official journal of the American Psychosomatic Society. The journal is published by Wolters Kluwer.
Researchers at UT Southwestern Medical Center at Dallas are looking for women to participate in the second phase of a study of a new cohesive silicone-gel breast implant.
Bayer HealthCare Pharmaceuticals Inc. announced today that its investigational compound regorafenib (BAY 73-4506) has been granted Fast Track designation by the U.S. Food and Drug Administration for the treatment of patients with metastatic and/or unresectable gastrointestinal stromal tumors (GIST) whose disease has progressed despite at least imatinib and sunitinib as prior treatments.
Young adults who were born prematurely show multiple biological signs of risks to future health, research from Imperial College London has found. The scientists, reporting their findings tomorrow in the journal Pediatric Research, say that the research indicates that urgent work is now needed to monitor preterm babies into adulthood to improve the detection of early signs of disease.
Cholesterol-lowering drugs known as statins are among the most prescribed medicines in the U.S. Now a new study by researchers at Fred Hutchinson Cancer Research Center indicates that statins may protect stem cell transplant patients from one of the most serious complications of the life-saving cancer therapy: graft-versus-host disease, or GVHD. The findings are reported in the Nov. 4 first edition of the journal Blood.
› Verified 1 days ago